Trials / Terminated
TerminatedNCT01141881
Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema
Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Mashhad University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Purpose: to evaluate the effect of intravitreal injection of tissue plasminogen activator(tPA) in treatment of refractory diabetic macular edema(DME).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tissue Plasminogen Activator,bevacizumab ,follow up | 25 microgram in 0.05 cc,1.25 mg in 0.05 cc,nothing |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-01-01
- Completion
- 2010-03-01
- First posted
- 2010-06-11
- Last updated
- 2010-10-08
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01141881. Inclusion in this directory is not an endorsement.